ArticleBMC pulmonary medicine2021
Recovery of physical function in lung transplant recipients with sarcopenia.
Article in BMC pulmonary medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 31 citations in OpenAlex.
- Prevalence and Clinical Correlates of Sarcopenia and Malnutrition in Lung Transplant Recipients Using EWGSOP2 and GLIM Criteria.Nutrients · 2026Article
- Sex Differences in Muscle-Respiratory Function Relationship in Lung Transplant Patients: A Longitudinal Study.Journal of cachexia, sarcopenia and muscle · 2026Article
- Sarcopenia trajectories and associated factors after lung transplantation: a growth mixture model study.Frontiers in medicine · 2026Article
- Review
- Effect of Total Psoas Muscle Area and Serum Albumin on Outcomes After Lung Transplantation.Clinical transplantation · 2025Article
- Factors Influencing the Attrition Rate of a 10-Week Multimodal Rehabilitation Program in Patients After Lung Transplant: A Neural Network Analysis.Healthcare (Basel, Switzerland) · 2024Article
- Long-term survival and clinical outcomes of delayed chest closure following lung transplantation.Surgery today · 2024Article
- Thoracic and vertebral deformities in lung transplantation: perioperative complications and long-term prognoses.BMC pulmonary medicine · 2024Article
- Native-lung complications following single-lung transplantation for interstitial lung disease: an in-depth analysis.BMC pulmonary medicine · 2024Article
- Letermovir prophylaxis for cytomegalovirus in lung-transplant recipients: a comprehensive study with literature review of off-label use and real-world experiences.Clinical and experimental medicine · 2024Review
- Article
- Roles of respirologists in lung transplantation in Japan: narrative review.Journal of thoracic disease · 2023Review
- Factors associated with quality of life in patients receiving lung transplantation: a cross-sectional study.BMC pulmonary medicine · 2023Article
- Thoracic mediastinal-occupying ratio predicts recovery and prognosis after lung transplantation.Interactive cardiovascular and thoracic surgery · 2022Article
- Efficacy and safety of mRNA SARS-CoV-2 vaccines in lung transplant recipients.Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy · 2022Article
- Sarcopenia as a Predictor of Short- and Long-Term Outcomes in Patients Surgically Treated for Malignant Pleural Mesothelioma.Cancers · 2022Article
- Outcome and prognostic factors after lung transplantation for bronchiectasis other than cystic fibrosis.BMC pulmonary medicine · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLung transplant (LTX) can provide a survival benefit and improve physical function for selected patients with advanced pulmonary disease. Sarcopenia is a systemic muscle-failure that can be found in a variety of life stages and disabilities. In this study, we follow the evolution of each variable defined in sarcopenia and the outcomes in LTX recipients with post-transplant sarcopenia.
methodsPatients who underwent LTX at Tohoku University Hospital between 2013 and 2018 were consecutively included in the retrospective cohort study, with follow-up to 2019. Sarcopenia was defined by low muscle mass (the cross-sectional area (CSA) of erector spinae muscle (ESM) in thoracic CT with a threshold < 17.24 cm
resultsFifty-five recipients were included into the study, of whom 19 patients were defined as sarcopenic and 36 as non-sarcopenic. The muscle mass improved after transplant in both sarcopenic and non-sarcopenic individuals: the median ESM-CSA enlarged from 17.25 cm
conclusionsEven patients with post-transplant sarcopenia have a chance to recover physical function to levels close to those without sarcopenia several years post LTX.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.